A$16.2 million - not enough to undertake a clinical trial in the USA and keep the lights on by the looks ... lucky the options could provide more $ I guess if the share price ever gets to the exercise price ?
So as at 31 March the company had $13.5 million and as at 30 June they only have $16.2 million with a $7 million injection during the quarter from the CR ... seems the June quarter was expensive - perhaps Ross got an expensive golden handshake ?
Ann: Quarterly Activity Report & Appendix 4C, page-2
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.005(1.85%) |
Mkt cap ! $50.58M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.0¢ | $42.84K | 157.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 31680 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 10983 | 1 |
View Market Depth
| Last trade - 13.08pm 07/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |